Étude de la cinétique de la bilirubine avant traitement par corticostéroïdes dans l'hépatite alcoolique aigüe sévère

Étude de la cinétique de la bilirubine avant traitement par corticostéroïdes dans l'hépatite alcoolique aigüe sévère Introduction: Acute alcoholic hepatitis (AAH) are treated by corticosteroid therapy (CT) when the Maddrey DF is = 32. The decrease in total bilirubin at day 7 is a major prognost...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux : Freyssinet Marie (Auteur), Archambeaud Isabelle (Directeur de thèse)
Collectivités auteurs : Université de Nantes 1962-2021 (Organisme de soutenance), Nantes Université Pôle Santé UFR Médecine et Techniques Médicales Nantes (Organisme de soutenance)
Format : Thèse ou mémoire
Langue : français
Titre complet : Étude de la cinétique de la bilirubine avant traitement par corticostéroïdes dans l'hépatite alcoolique aigüe sévère / Marie Freyssinet; sous la direction de Isabelle Archambeaud
Publié : [S.l.] : [s.n.] , 2013
Accès en ligne : Accès Nantes Université
Note de thèse : Reproduction de : Thèse d'exercice : Médecine. Hépato-gastroentérologie : Nantes : 2013
Sujets :
Documents associés : Reproduction de: Étude de la cinétique de la bilirubine avant traitement par corticostéroïdes dans l'hépatite alcoolique aigüe sévère
Description
Résumé : Étude de la cinétique de la bilirubine avant traitement par corticostéroïdes dans l'hépatite alcoolique aigüe sévère Introduction: Acute alcoholic hepatitis (AAH) are treated by corticosteroid therapy (CT) when the Maddrey DF is = 32. The decrease in total bilirubin at day 7 is a major prognostic factor and a component of the Lille model predicting survival. The aim of our study was to evaluate the impact on survival of the evolution of biological variables as bilirubin in the week before CT initiation. Patients and methods: 106 patients consecutively hospitalized from January 2007 to December 2010 for a severe acute alcoholic hepatitis and having a DF = 32 were included for a retrospective study. Clinical and laboratory data were collected at admission and during hospitalization. All received CT and were alive 7 days after CT initiation; 28 also received N-acetyl cysteine (NAC). Variables affecting survival were analyzed in a Cox model. Results: Mean age was 53 (24-74), 61% were male and 85% had cirrhosis. All patients had an active consumption of alcohol. The mean time between admission and initiation of CT was 10 days (4-31). The 3 and 6-months survivals were 69 % and 60 %. In multivariate analysis, younger patients (p=0.04), decrease in bilirubin level at 7 days CT (p <0.0002), and decrease of bilirubin before steroid (DBBS) (p< 0. 0003) had better3-months survival. DBBS was observed in 55% of patients and 88% with DBBS were still alive at 3 months vs 40% without DBBS. This later variable was related to response to CT and adding the DBBS variable to Lille Model or DF increased the AUROC. Conclusion: The present study indicates that in patients with severe acute alcoholic hepatitis, DBBS is a significantly independent predictor for both the response to CT and the 3 months survival. This could help to rapidly define the patients with a poor prognostic for whom other therapies than CT could be attempted such as transplantation or bio-artificial livers.
Configuration requise : Un logiciel capable de lire un fichier au format PDF
Bibliographie : Bibliogr. 41 réf.